BML, Inc. (BMLKF)

Market Cap	938.20M +23.0%
Revenue (ttm)	950.88M +5.5%
Net Income	48.22M +24.3%
EPS	1.25 +26.1%
Shares Out	n/a
PE Ratio	19.46
Forward PE	n/a
Dividend	0.78 (3.09%)
Ex-Dividend Date	Mar 30, 2026

Volume	11,479
Average Volume	4,870
Open	25.21
Previous Close	24.10
Day's Range	25.21 - 25.21
52-Week Range	20.30 - 25.21
Beta	0.21
RSI	n/a
Earnings Date	May 8, 2026

About BML, Inc.

BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispe...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1955
• Employees: 4,558
• Stock Exchange: OTCMKTS
• Ticker Symbol: BMLKF

Financial Performance

In fiscal year 2025, BML, Inc.'s revenue was 143.19 billion, an increase of 3.79% compared to the previous year's 137.96 billion. Earnings were 6.26 billion, an increase of 3.80%.

Financial numbers in JPY